Literature DB >> 19636650

Growing evidence that radionuclide imaging identifies management strategies that improve outcome.

Michael R Freeman.   

Abstract

Mesh：

Year:  2009        PMID： 19636650     DOI： 10.1007/s12350-009-9120-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  16 in total

1.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group.

Authors:  L J Shaw; R Hachamovitch; D S Berman; T H Marwick; M S Lauer; G V Heller; A E Iskandrian; K L Kesler; M I Travin; H C Lewin; R C Hendel; S Borges-Neto; D D Miller
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

Review 2.  Cost-effectiveness of myocardial perfusion imaging: a summary of the currently available literature.

Authors:  Roger D Des Prez; Leslee J Shaw; Robert L Gillespie; Wael A Jaber; Gavin L Noble; Prem Soman; David G Wolinsky; Kim A Williams
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

3.  A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study.

Authors:  Don Poldermans; Olaf Schouten; Radosav Vidakovic; Jeroen J Bax; Ian R Thomson; Sanne E Hoeks; Harm H H Feringa; Martin Dunkelgrün; Peter de Jaegere; Alexander Maat; Marc R H M van Sambeek; Miklos D Kertai; Eric Boersma
Journal:  J Am Coll Cardiol       Date:  2007-04-16       Impact factor: 24.094

4.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

5.  Prognosis in medically stabilized unstable angina: early Holter ST-segment monitoring compared with predischarge exercise thallium tomography.

Authors:  J D Marmur; M R Freeman; A Langer; P W Armstrong
Journal:  Ann Intern Med       Date:  1990-10-15       Impact factor: 25.391

6.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Authors:  Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko
Journal:  J Am Coll Cardiol       Date:  2007-10-10       Impact factor: 24.094

7.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

8.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

Authors:  Lawrence H Young; Frans J Th Wackers; Deborah A Chyun; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Gary V Heller; Ami E Iskandrian; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

9.  Does myocardial perfusion scintigraphy predict improvement in symptoms and exercise capacity following successful elective percutaneous coronary intervention?

Authors:  M Bashar Al-Housni; Fiona Hutchings; Miles Dalby; Michael Dubowitz; Richard Grocott-Mason; Charles D J Ilsley; Mark Mason; Andrew G Mitchell; Andrew D Kelion
Journal:  J Nucl Cardiol       Date:  2009-07-09       Impact factor: 5.952

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.